将实验治疗臂添加到正在进行的多臂多阶段平台试验中.
Thomas Burnett1, Franz König2, Thomas Jaki3,4
1Department of Mathematical Sciences, University of Bath, Bath, UK.
Statistics in medicine
|June 9, 2024
概括
多臂多阶段 (MAMS) 平台试验可以在研究期间添加新的治疗方法. 这种方法确保了统计有效性和错误率控制,在将新假设纳入正在进行的试验时.
科学领域:
- 临床试验方法论 临床试验方法论
- 统计推理 统计推理
- 生物统计学 生物统计学
背景情况:
- 多臂多阶段 (MAMS) 平台试验可以有效地比较多种治疗与共同的对照.
- 这些设计本质上允许进行多重性调整,这对于保持统计完整性至关重要,特别是在不同的剂量或给药途径的情况下.
- 为了实际和统计效率,在正在进行的试验中添加新疗法是可取的.
研究的目的:
- 展示一种方法,在正在进行的MAMS平台试验中添加新的治疗臂.
- 为了确保家庭智能错误率 (FWER) 仍然受到严格控制,尽管设计修改.
- 调整现有的统计程序以纳入未计划的假设.
主要方法:
- 使用条件错误方法将新假设整合到FWER控制的测试程序中.
- 应用该框架来为已经进行的MAMS试验添加治疗方法.
- 使用模拟来评估拟议程序的特征.
主要成果:
- 条件错误方法为添加假设到FWER控制的程序提供了一个有效的框架.
- 这种方法成功地允许将新疗法纳入正在进行的MAMS试验.
- 模拟显示了这种修改试验设计的可行性和特征.
结论:
- 条件错误方法是一种强大的统计工具,可以提高MAMS平台试验的灵活性.
- 它可以无地添加新的治疗方法,而不会影响整体的统计有效性.
- 这种方法支持自适应性临床试验设计,提高效率和响应性.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...


